These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10530773)

  • 21. Homotypic cell-cell contacts stimulate the motile activity of rat prostate cancer cells.
    Madeja Z; Miekus K; Sroka J; Djamgoz MB; Korohoda W
    BJU Int; 2001 Nov; 88(7):776-86. PubMed ID: 11890253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells.
    Ke Y; Jing C; Barraclough R; Smith P; Davies MP; Foster CS
    Int J Cancer; 1997 May; 71(5):832-7. PubMed ID: 9180153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer.
    Tiwari RK; Geliebter J; Garikapaty VP; Yedavelli SP; Chen S; Mittelman A
    Int J Oncol; 1999 Apr; 14(4):713-9. PubMed ID: 10087319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in expression of oligosaccharide determinants by phenotypically distinct sublines of the Dunning 3327 rat prostate cancer.
    Abel PD; Foster CS; Tebbutt S; Williams G
    J Urol; 1990 Sep; 144(3):760-5. PubMed ID: 2388349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pentosan, a novel cancer chemotherapeutic agent, on prostate cancer cell growth and motility.
    Pienta KJ; Murphy BC; Isaacs WB; Isaacs JT; Coffey DS
    Prostate; 1992; 20(3):233-41. PubMed ID: 1374181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity.
    Mycielska ME; Fraser SP; Szatkowski M; Djamgoz MB
    J Cell Physiol; 2003 Jun; 195(3):461-9. PubMed ID: 12704656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells.
    Ke Y; Beesley C; Smith P; Barraclough R; Rudland P; Foster CS
    Br J Cancer; 1998; 77(2):287-96. PubMed ID: 9461000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT; Yu GW; Coffey DS
    Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of malotilate on invasion and metastasis of rat mammary carcinoma cells by modifying the functions of vascular endothelial cells.
    Nagayasu H; Hamada J; Kawano T; Konaka S; Nakata D; Shibata T; Arisue M; Hosokawa M; Takeichi N; Moriuchi T
    Br J Cancer; 1998 May; 77(9):1371-7. PubMed ID: 9652751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of castanospermine on the metastatic properties of prostate cancer cells.
    Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
    Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels.
    Gumushan Aktas H; Akgun T
    Biomed Pharmacother; 2018 Oct; 106():770-775. PubMed ID: 29990870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line.
    Miki T; Nonomura N; Nozawa M; Harada Y; Nishimura K; Kojima Y; Takahara S; Okuyama A
    J Urol; 1998 Jul; 160(1):210-3. PubMed ID: 9628652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis.
    Dandekar DS; Lokeshwar VB; Cevallos-Arellano E; Soloway MS; Lokeshwar BL
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):59-66. PubMed ID: 12734674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of skeletal muscle-type voltage-gated Na+ channel in rat and human prostate cancer cell lines.
    Diss JK; Stewart D; Fraser SP; Black JA; Dib-Hajj S; Waxman SG; Archer SN; Djamgoz MB
    FEBS Lett; 1998 May; 427(1):5-10. PubMed ID: 9613589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor.
    Heston WD; Kadmon D; Fair WR
    Cancer Lett; 1981 Jul; 13(2):139-45. PubMed ID: 7306951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morpho-physiological heterogeneity of cells within two rat prostate carcinoma cell lines AT-2 and MAT-LyLu differing in the degree of malignancy observed by cell cloning and the effects of caffeine, theophylline and papaverine upon a proportion of the clones.
    Musialik E; Ryszawy D; Madeja Z; Korohoda W
    Oncol Rep; 2013 May; 29(5):1789-96. PubMed ID: 23467722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumoral local effect and metastatic risk of focused extracorporeal pyrotherapy on Dunning R-3327 tumors.
    Bataille N; Vallancien G; Chopin D
    Eur Urol; 1996; 29(1):72-7. PubMed ID: 8821695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single cell adhesion measuring apparatus (SCAMA): application to cancer cell lines of different metastatic potential and voltage-gated Na+ channel expression.
    Palmer CP; Mycielska ME; Burcu H; Osman K; Collins T; Beckerman R; Perrett R; Johnson H; Aydar E; Djamgoz MB
    Eur Biophys J; 2008 Apr; 37(4):359-68. PubMed ID: 17879092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
    Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW
    Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the antitumour activity of coumarin in prostate cancer models.
    Maucher A; Kager M; von Angerer E
    J Cancer Res Clin Oncol; 1993; 119(3):150-4. PubMed ID: 8418087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.